It seems the World Health Organization is pressing on with its plans to test out the “biological qualifier” for all biologic medicines despite calls from the European generics and biosimilars industry for the project to be put on hold pending an assessment of the impact of the proposal on access to medicines.
At its 62nd INN consultation on international non-proprietary names (INNs) in April this year, the WHO’s INN Expert...






